This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moser, K. M. Articles by Pedersen, C. Search for Related Content PubMed PubMed Citation Articles by Moser, K. M. Articles by Pedersen, C.

Circulation, Vol 83, 1371-1379, Copyright © 1991 by American Heart Association

ARTICLES

Chronic pulmonary thromboembolism in dogs treated with tranexamic acid

KM Moser, JP Cantor, M Olman, I Villespin, JL Graif, R Konopka, JJ Marsh and C Pedersen
Pulmonary and Critical Care Division, University of California, School of Medicine, San Diego 92103-1990.

BACKGROUND. Many questions remain regarding the pathogenesis, natural history, diagnosis, and treatment of chronic thromboembolic pulmonary hypertension in patients. To answer such questions, we developed an animal model of this disorder. The brisk thrombolytic response of canines to acute embolism has, previously, prevented the establishment of such a model. METHODS AND RESULTS. The fibrinolytic inhibitor tranexamic acid was given orally to canines before, and for intervals after, pulmonary emboli were released from venous thrombi formed in vivo in femoral veins or the inferior vena cava. Preliminary studies disclosed that embolic residuals from femoral vein thrombi were not sufficient to cause significant, persistent pulmonary hypertension. With repetitive, larger thrombi embolized from the inferior vena cava, however, persistent pulmonary hypertension was achieved in most animals. CONCLUSIONS. Resolution of emboli in the canine can be inhibited by tranexamic acid. As in humans, a spectrum of embolic residuals is encountered, and the perfusion lung scan consistently underestimates the extent of embolic residuals. Studies of this animal model continue.

This article has been cited by other articles:

				T. A. Morris, J. J. Marsh, P. G. Chiles, W. R. Auger, P. F. Fedullo, and V. L. Woods Jr. Fibrin Derived from Patients with Chronic Thromboembolic Pulmonary Hypertension Is Resistant to Lysis Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1270 - 1275. [Abstract] [Full Text] [PDF]

				T. A. Morris, J. J. Marsh, P. G. Chiles, C. A. Pedersen, R. G. Konopka, A. C. Gamst, and O. Loza Embolization itself stimulates thrombus propagation in pulmonary embolism Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H818 - H822. [Abstract] [Full Text] [PDF]

				E. Fadel, J. Y. Riou, M. Mazmanian, P. Brenot, E. Dulmet, H.čn. Detruit, A. Serraf, E. A. Bacha, P. Herve, and P. Dartevelle PULMONARY THROMBOENDARTERECTOMY FOR CHRONIC THROMBOEMBOLIC OBSTRUCTION OF THE PULMONARY ARTERY IN PIGLETS J. Thorac. Cardiovasc. Surg., April 1, 1999; 117(4): 787 - 793. [Abstract] [Full Text] [PDF]